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Abstract: The study of the intestinal microbiota is one of the greatest challenges in today’s clinical
environment. Thus, probiotics have been established as a focus for its stability, as they play a key
role in its regulation. The development of an automated technique that allows the practitioners the
smooth search for the optimal probiotic is postulated as the main objective of this study. Despite the
existence of previous attempts at applications for this purpose, they have only been carried out for
the countries of origin, preventing them from being used in others such as Spain. Therefore, a system
has been developed with open, multi-platform, and free technologies, which manages to locate the
optimal probiotic for each pathology.
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1. Introduction
The human microbiome is the population of all microorganisms with their genes and metabolites
that colonize the body. The highest concentration of microbes is found in the intestine and is called
intestinal microbiota. The flora of the microbiome has a significant impact on human health, and
understanding its effects is one of the most salient challenges facing clinical care nowadays. Intake
of the right amount of the appropriate microorganisms can help regenerate the composition and
concentration of the microbiota, thus eliminating problems such as dysbiosis [1]. Moreover, bearing in
mind the current situation with the Covid-19 pandemic disease, it has been highlighted how alterations
in the microbiota may be linked to individual severity with which each patient is affected [2]. A detailed
report of the SEPyP (Probióticos, prebióticos y salud) clarified that for a microorganism to be qualified
as probiotic it is necessary to scientifically demonstrate that it produces beneficial effects on human
health [3]. Furthermore, pharmacists and doctors themselves have started to use probiotics for certain
treatments. The data and studies that have been published with clinical results for probiotics strains
are beginning to be abundant to such an extent that a professional in the field cannot afford to know
all the probiotic products with the clinical evidence that exists.
2. Objective
The main objective of the present work is to simplify the consultation process, so that with a
simple, agile, and intuitive application, the search and consultation will be quick and effective, so that
the doctor or pharmacist will have all the information available to treat and advise his patients, easily
selecting the suitable product, dose, and format for a particular indication.
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3. State-of-the-Art
Undeniably, the healthcare world is evolving towards a more technological environment where
there are more and more applications that support clinicians in diagnosing pathologies, making
decisions, and even prescribing medical treatment to ensure that the medication and its dosage is
indeed recommended. The Clinical Guide to Probiotic Product application is a guide to the scientific
evidence available for probiotic products that was created with published data from clinical studies
for various probiotic strains. Currently, there are two released for products available and supported in
Canada and United States [4,5]. Besides the information being extremely worthwhile, due to differences
in the commercial products in Spain, it lacks usability.
4. Methodology
This paper presents a prescription assistance system that has been developed with the aim of
providing a tool that includes the products endorsed in Spain for later consultation. The system
developed has a webpage that enables remote consultation of the appropriate probiotics for a specific
pathology in a very simple way (Figure 1a). Once the pathology has been selected, the available
probiotics are shown, ordered by the level of evidence. In addition, the system designed is not intended
to be static and has an administration panel that allows you to create, edit, or delete information of all
kinds. It is also possible to access quick actions to view details, edit, or delete (Figure 1b).
(a) Homepage (b) List of evidence of probiotic
Figure 1. Application developed.
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